{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T11:10:19Z","timestamp":1722251419366},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2434,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1111\/j.1365-2133.2008.08886.x","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T09:21:00Z","timestamp":1224148860000},"page":"92-102","source":"Crossref","is-referenced-by-count":19,"title":["Psoralen plus ultraviolet A\u2003\u00b1\u2003interferon-\u03b1 treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-\u03baB and T-cell receptor pathways"],"prefix":"10.1093","volume":"160","author":[{"given":"M.B.","family":"Wozniak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tracey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.L.","family":"Ortiz-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fern\u00e1ndez Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Rodriguez-Peralto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u00c1.","family":"Piris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Villuendas (deceased)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0190-9622(80)80385-9","article-title":"Cutaneous T cell lymphoma: mycosis fungoides, S\u00e9zary syndrome, and other variants","volume":"2","author":"Edelson","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB2","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Girardi","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB3","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2000.18.15.2908","article-title":"Primary cutaneous T-cell lymphoma: review and current concepts","volume":"18","author":"Siegel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB4","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1182\/blood-2006-08-037192","article-title":"The mitochondrial effects of novel apoptogenic molecules generated by psoralen photolysis as a crucial mechanism in PUVA therapy","volume":"109","author":"Caffieri","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB6","doi-asserted-by":"crossref","first-page":"26589","DOI":"10.1074\/jbc.M301491200","article-title":"The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter","volume":"278","author":"Xie","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1396-0296.2003.01643.x","article-title":"Interferon in the treatment of cutaneous T-cell lymphoma","volume":"16","author":"Olsen","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cncr.10706","article-title":"Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma","volume":"95","author":"Chiarion-Sileni","year":"2002","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0609.2005.00497.x","article-title":"Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides","volume":"75","author":"Rupoli","year":"2005","journal-title":"Eur J Haematol"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2008.08886.x-BIB10","first-page":"18s","article-title":"Prospective, randomized, multicentre clinical trial on the use of interferon a-2a plus PUVA versus PUVA monotherapy in patients with cutaneous T-cell lymphoma, stages I and II","volume":"24","author":"Stadler","year":"2006","journal-title":"J Clin Oncology, ASCO Annual Meeting Proceedings Part I"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V80.3.744.744","article-title":"Correlation between interferon (IFN) alpha resistance and deletion of the IFN alpha\/beta genes in acute leukemia cell lines suggests selection against the IFN system","volume":"80","author":"Colamonici","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.thj.6200004","article-title":"Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression","volume":"1","author":"Landolfo","year":"2000","journal-title":"Hematol J"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB13","doi-asserted-by":"crossref","first-page":"12379","DOI":"10.1074\/jbc.M310787200","article-title":"Identification of a novel conserved motif in the STAT family that is required for tyrosine phosphorylation","volume":"279","author":"Gamero","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB14","first-page":"42","article-title":"The suppressor of cytokine signaling-1 is constitutively expressed in chronic myeloid leukemia and correlates with poor cytogenetic response to interferon-alpha","volume":"89","author":"Roman-Gomez","year":"2004","journal-title":"Haematologica"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB15","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1073\/pnas.95.10.5568","article-title":"STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities","volume":"95","author":"Yang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB16","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1182\/blood.V91.2.570","article-title":"Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression","volume":"91","author":"Sun","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB17","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1002\/j.1460-2075.1994.tb06932.x","article-title":"Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta","volume":"13","author":"Abramovich","year":"1994","journal-title":"EMBO J"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB18","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1073\/pnas.88.24.11455","article-title":"High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons","volume":"88","author":"McKendry","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB19","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood.V92.5.1668","article-title":"A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons","volume":"92","author":"Sakamoto","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB20","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0002-9440(10)64459-8","article-title":"Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma","volume":"161","author":"Tracey","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/107999004322917034","article-title":"Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma","volume":"24","author":"Tracey","year":"2004","journal-title":"J Interferon Cytokine Res"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/emboj\/21.5.954","article-title":"Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt\u2019s lymphoma","volume":"21","author":"Nanbo","year":"2002","journal-title":"EMBO J"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB23","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2002-11-3574","article-title":"Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study","volume":"102","author":"Tracey","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB24","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB26","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB27","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1158\/1078-0432.CCR-04-0753","article-title":"Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement","volume":"10","author":"Rodr\u00edguez","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1023\/A:1008314804492","article-title":"The interferon-alpha regulation of interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in carcinoid tumors","volume":"11","author":"Zhou","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2353\/ajpath.2006.060079","article-title":"Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis","volume":"169","author":"Wolf","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1471-4159.2001.00604.x","article-title":"BMCP1: a mitochondrial uncoupling protein in neurons which regulates mitochondrial function and oxidant production","volume":"79","author":"Kim-Han","year":"2001","journal-title":"J Neurochem"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/sj.bjc.6601115","article-title":"Suppressor of cytokine signalling gene expression is elevated in breast carcinoma","volume":"89","author":"Raccurt","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.leu.2404970","article-title":"Lymphoma microenvironment: culprit or innocent?","volume":"22","author":"Herreros","year":"2008","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB33","first-page":"1416","article-title":"Multidrug resistance in cancer therapy: role of the microenvironment","volume":"4","author":"Galmarini","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.blre.2005.08.003","article-title":"Tumor microenvironment and drug resistance in hematologic malignancies","volume":"20","author":"Li","year":"2006","journal-title":"Blood Rev"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10555-006-9010-6","article-title":"Intratumoral cytokines\/chemokines\/growth factors and tumor infiltrating dendritic cells: friends or enemies?","volume":"25","author":"Shurin","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","article-title":"Smoldering and polarized inflammation in the initiation and promotion of malignant disease","volume":"7","author":"Balkwill","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB37","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1073\/pnas.93.17.9148","article-title":"Activation of Jak\/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and S\u00e9zary syndrome","volume":"93","author":"Zhang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB38","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2006-12-063644","article-title":"NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis","volume":"110","author":"G\u00f6thert","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB39","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2003-07-2340","article-title":"Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines","volume":"103","author":"Nefedova","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB40","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2403385","article-title":"In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3","volume":"18","author":"Sommer","year":"2004","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1074-7613(00)80005-9","article-title":"Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils","volume":"10","author":"Takeda","year":"1999","journal-title":"Immunity"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB42","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V97.4.1056","article-title":"STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma","volume":"97","author":"Brender","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB43","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminoncol.2005.12.015","article-title":"Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL)","volume":"33","author":"Whittaker","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB44","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood-2006-02-003988","article-title":"Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells","volume":"109","author":"Bhardwaj","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2008.08886.x-BIB45","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","article-title":"Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis","volume":"107","author":"Sors","year":"2006","journal-title":"Blood"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2008.08886.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2008.08886.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:43:01Z","timestamp":1676382181000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/160\/1\/92\/6641644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08886.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}